Näytä suppeat kuvailutiedot

dc.contributor.authorRoine, Eija
dc.contributor.authorSintonen, Harri
dc.contributor.authorKellokumpu-Lehtinen, Pirkko-Liisa
dc.contributor.authorPenttinen, Heidi
dc.contributor.authorUtriainen, Meri
dc.contributor.authorVehmanen, Leena
dc.contributor.authorHuovinen, Riika
dc.contributor.authorKautiainen, Hannu
dc.contributor.authorNikander, Riku
dc.contributor.authorBlomqvist, Carl
dc.contributor.authorSaarto, Tiina
dc.date.accessioned2020-03-09T10:03:39Z
dc.date.available2020-03-09T10:03:39Z
dc.date.issued2020
dc.identifier.citationRoine, E., Sintonen, H., Kellokumpu-Lehtinen, P.-L., Penttinen, H., Utriainen, M., Vehmanen, L., Huovinen, R., Kautiainen, H., Nikander, R., Blomqvist, C., & Saarto, T. (2020). Health-related Quality of Life of Breast Cancer Survivors Attending an Exercise Intervention Study : A Five-year Follow-up. <i>In Vivo</i>, <i>34</i>(2), 667-674. <a href="https://doi.org/10.21873/invivo.11821" target="_blank">https://doi.org/10.21873/invivo.11821</a>
dc.identifier.otherCONVID_34925698
dc.identifier.urihttps://jyx.jyu.fi/handle/123456789/68104
dc.description.abstractBackground/Aim: As the number of breast cancer survivors is increasing, their long-term health-related quality of life (HRQoL)has become an important issue. The aim of the study is to follow up the HRQoL of breast cancer survivors (BCS) in a prospectiverandomized exercise intervention study and to compare HRQoL to that of the age-matched general female population. Patients and Methods: Following adjuvant treatment, 537 patients aged 35-68 and capable of exercise training were randomized to a 12-monthexercise trial. In 182 of those patients, HRQoL was measured by the generic 15D at baseline and followed up for five years.Furthermore, the HRQoL of all BCS answering the 15D at five-year follow-up (n=390) was compared to that of a representativesample of the general population. Results: After five years, the BCS' mean HRQoL demonstrated a statistically and clinicallysignificant impairment compared to that of the general population (difference −0.023, p<0.001). The mean HRQoL of BCS followedup from baseline until five years did not improve significantly (change=0.007, p=0.27), whereas the dimensions of usual activities(0.043, p=0.004), depression (0.038, p=0.007), distress (0.030, p=0.036), and sexual activity (0.057, p=0.009) did. Conclusion:The HRQoL of BCS was still impaired five years following treatment.en
dc.format.mimetypeapplication/pdf
dc.languageeng
dc.language.isoeng
dc.publisherInternational Institute of Anticancer Research
dc.relation.ispartofseriesIn Vivo
dc.rightsIn Copyright
dc.subject.otherbreast cancer
dc.subject.othercancer
dc.subject.otherexercise
dc.subject.othergeneral population
dc.subject.otherhealth-related quality of life
dc.subject.otherphysical activity
dc.subject.otherquality of life
dc.subject.otherrehabilitation
dc.subject.otherutility
dc.titleHealth-related Quality of Life of Breast Cancer Survivors Attending an Exercise Intervention Study : A Five-year Follow-up
dc.typearticle
dc.identifier.urnURN:NBN:fi:jyu-202003092339
dc.contributor.laitosLiikuntatieteellinen tiedekuntafi
dc.contributor.laitosFaculty of Sport and Health Sciencesen
dc.contributor.oppiaineGerontologia ja kansanterveysfi
dc.contributor.oppiaineGerontology and Public Healthen
dc.type.urihttp://purl.org/eprint/type/JournalArticle
dc.type.coarhttp://purl.org/coar/resource_type/c_2df8fbb1
dc.description.reviewstatuspeerReviewed
dc.format.pagerange667-674
dc.relation.issn0258-851X
dc.relation.numberinseries2
dc.relation.volume34
dc.type.versionpublishedVersion
dc.rights.copyright© 2020, International Institute of Anticancer Research (Dr. George J. Delinasios)
dc.rights.accesslevelopenAccessfi
dc.subject.ysorintasyöpä
dc.subject.ysoelämänlaatu
dc.subject.ysohyvinvointi (terveydellinen)
dc.subject.ysoliikuntahoito
dc.subject.ysoseurantatutkimus
dc.subject.ysokuntoutujat
dc.subject.ysosyöpähoidot
dc.subject.ysokuntoutus
dc.format.contentfulltext
jyx.subject.urihttp://www.yso.fi/onto/yso/p20019
jyx.subject.urihttp://www.yso.fi/onto/yso/p10759
jyx.subject.urihttp://www.yso.fi/onto/yso/p22036
jyx.subject.urihttp://www.yso.fi/onto/yso/p7811
jyx.subject.urihttp://www.yso.fi/onto/yso/p13719
jyx.subject.urihttp://www.yso.fi/onto/yso/p23131
jyx.subject.urihttp://www.yso.fi/onto/yso/p27422
jyx.subject.urihttp://www.yso.fi/onto/yso/p3320
dc.rights.urlhttp://rightsstatements.org/page/InC/1.0/?language=en
dc.relation.doi10.21873/invivo.11821
jyx.fundinginformationThe writing of this article was supported by a research grant from the Ida Montin foundation. The BREX study was supported by the Cancer Society of Finland.
dc.type.okmA1


Aineistoon kuuluvat tiedostot

Thumbnail

Aineisto kuuluu seuraaviin kokoelmiin

Näytä suppeat kuvailutiedot

In Copyright
Ellei muuten mainita, aineiston lisenssi on In Copyright